Showing results (971-980 of 6,768) with videos related to

Sort By:
Pageof 677
Clinical Therapeutics|April 30, 2013
Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011Sam K Bouchillon, Robert E Badal, Daryl J Hoban, et al.
Clinical Therapeutics|July 9, 2013
Differences in adherence to osteoporosis regimens: a 2-year analysis of a population treated under specific guidelinesTien-Tsai Cheng, Shan-Fu Yu, Chung-Yuan Hsu, et al.
Clinical Therapeutics|April 2, 2013
Utility and work productivity data for economic evaluation of breast cancer therapies in the Netherlands and SwedenGerardus W J Frederix, Nuz Quadri, Anke M Hövels, et al.
Clinical Therapeutics|April 2, 2013
Patient-level medication regimen complexity across populations with chronic diseaseAnne M Libby, Douglas N Fish, Patrick W Hosokawa, et al.
Clinical Therapeutics|April 2, 2013
Medicare Part D research highlights and policy updates, 2013: impact and insightsJoAnn Stubbings, Denys T Lau
Clinical Therapeutics|May 8, 2012
Cost-effectiveness model of use of genetic testing as an aid in assessing the likely benefit of aspirin therapy for primary prevention of cardiovascular diseaseDov Shiffman, Katherine Slawsky, Lauren Fusfeld, et al.
Clinical Therapeutics|June 15, 2012
Economic impact of using additional diagnostic tests to better select patients with stroke for intravenous thrombolysis in the United KingdomStephanie R Earnshaw, Cheryl McDade, Ann-Marie Chapman, et al.
Clinical Therapeutics|October 8, 2013
Ceftazidime dosage recommendations in burn patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulationsJean-Marie Conil, Bernard Georges, François Ravat, et al.
Clinical Therapeutics|October 8, 2013
Setipiprant, a selective oral antagonist of human CRTH2: relative bioavailability of a capsule and a tablet formulation in healthy female and male subjectsDaniela Baldoni, Alison Mackie, Marcelo Gutierrez, et al.
Clinical Therapeutics|October 22, 2013
Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysisRhynn J Malloy, Abir O Kanaan, Matthew A Silva, et al.
Pageof 677